CoChat

Review of Maintenance Trials for Major Depressive Disorder: A 25-Year Perspective From the US Food and Drug Administration

Borges, Silvana, Chen, Yeh-Fong, Laughren, Thomas P., Temple, Robert, Patel, Hiren D., David, Paul A., Mathis, Mitchell, Unger, Ellis, Yang, Peiling, Khin, Ni A. · 2014 · The Journal of Clinical Psychiatry

The DOI matches its Crossref record.

Abstract

Article AbstractObjective: The maintenance efficacy of antidepressants is usually assessed in postmarketing studies with a randomized withdrawal design. This report explores differences in relapse rates, trial characteristics, and success rates in maintenance efficacy studies submitted to the US Food and Drug Administration (FDA) over a 25-year period. Data Sources: Clinical data from all maintenance trials with antidepressants submitted to FDA between 1987 and 2012. Study Selection: Efficacy data were compiled from 15 maintenance clinical trials in adults diagnosed with major depressive disorder according to DSM-III or DSM-IV criteria. Data Extraction: Trial characteristics, relapse rates, and time to relapse in each study were examined. Results: Relapse rates were significantly lower (P < .05) in the drug arm than in the placebo arm in every study, with a mean relapse rate difference of 18% and an average percent reduction in relapse rate of 52% compared to placebo. Only 6% of the relapse events occurred in the first 2 weeks of the double-blind phase. The separation between treatment arms continued to increase throughout the double-blind phase only in the trial with longest response stabilization period. Conclusions: Antidepressant maintenance trials have a high rate of success, indicating a benefit of continuing drug treatment after initial response to an antidepressant. This benefit appears to result mainly from a decreased rate of recurrent depression rather than from an effect of drug withdrawal in the placebo groups. J Clin Psychiatry 2014;75(3):205-214 © Copyright 2014 Physicians Postgraduate Press, Inc. Submitted: August 7, 2013; accepted November 27, 2013 (doi:10.4088/JCP.13r08722). Corresponding author: Silvana Borges, MD, Division of Psychiatry Products, HFD-130, Food and Drug Administration, 10903 New Hampshire Ave, Bldg 22, Rm 4159, Silver Spring, MD 20993-0002 (silvana.borges@fda.hhs.gov).

Overview

Integrity signals

Registry

Crossref · 10.4088/jcp.13r08722

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

5 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Still being checked.

Cited by

See all 109

Metadata

Authors
Borges, S., Chen, Y.-F., Laughren, T. P., Temple, R., Patel, H. D., David, P. A., Mathis, M., Unger, E., Yang, P., & Khin, N. A.
Affiliations
United States Food and Drug Administration (US)
Corresponding author
Borges, Silvana
Venue
The Journal of Clinical Psychiatry
Published
2014-03-15
Volume
75
Issue
03
Pages
205-214
ISSN
0160-6689 (ISSN-L)
OpenAlex
W1968103182
Cited by
109
References
0
Citations by year
2026: 1 · 2025: 5 · 2024: 5 · 2023: 8 · 2022: 9 · 2021: 7 · 2020: 11 · 2019: 19 · 2018: 10 · 2017: 12 · 2016: 11 · 2015: 8 · 2014: 3
FWCI
8.26
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Keywords
major depressive disorder, antidepressant maintenance, relapse rate, recurrent depression, time to relapse, drug withdrawal, post-marketing studies
MeSH terms
Adult, Major Depressive Disorder, Depressive Disorder, Major, Female, Humans, Male, Middle Aged, Time Factors, United States, United States Food and Drug Administration, Randomized Controlled Trials as Topic, Treatment Outcome, Withholding Treatment, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Review of Maintenance Trials for Major Depressive Disorder: A 25-Year Perspective From the US Food and Drug Administration. https://app.cochat.ai/papers/10.4088/jcp.13r08722
The paper
Borges, S., Chen, Y.-F., Laughren, T. P., Temple, R., Patel, H. D., David, P. A., Mathis, M., Unger, E., Yang, P., & Khin, N. A. (2014). Review of Maintenance Trials for Major Depressive Disorder: A 25-Year Perspective From the US Food and Drug Administration. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.13r08722

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.